{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:32:33Z","timestamp":1773833553182,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s13730-018-0311-8","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T21:25:11Z","timestamp":1517433911000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-8107","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Glaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"10","key":"311_CR1","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982\u20134.","journal-title":"J Gastroenterol"},{"issue":"1","key":"311_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/BOR.0b013e3283413011","volume":"23","author":"JT Geyer","year":"2011","unstructured":"Geyer JT, Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol. 2011;23(1):95\u2013101.","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"311_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrgastro.2010.81","volume":"7","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa T, Takuma K, Egawa N, et al. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7(7):401\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"311_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.178.2.661","volume":"178","author":"MH Tao","year":"1993","unstructured":"Tao MH, Smith RI, Morrison SL. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med. 1993;178(2):661\u20137.","journal-title":"J Exp Med"},{"issue":"1","key":"311_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","volume":"23","author":"A Nirula","year":"2011","unstructured":"Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23(1):119\u201324.","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"311_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392.","journal-title":"Mod Pathol"},{"issue":"7","key":"311_CR7","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688\u201399.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"311_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.humpath.2009.10.019","volume":"41","author":"D Dhall","year":"2010","unstructured":"Dhall D, Suriawinata AA, Tang LH, et al. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010;41(5):643\u201352.","journal-title":"Hum Pathol"},{"issue":"Suppl 18","key":"311_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","volume":"42","author":"ST Chari","year":"2007","unstructured":"Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic\u2019s HISORt criteria. J Gastroenterol. 2007;42(Suppl 18):39\u201341.","journal-title":"J Gastroenterol"},{"issue":"1","key":"311_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"311_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ki.2012.382","volume":"83","author":"MP Alexander","year":"2013","unstructured":"Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83(3):455\u201362.","journal-title":"Kidney Int"},{"issue":"3","key":"311_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0971-4065.143300","volume":"25","author":"AA Kurien","year":"2015","unstructured":"Kurien AA, Raychaudhury A, Walker PD. Membranous nephropathy as a rare renal manifestation of IgG4-related disease. Indian J Nephrol. 2015;25(3):164\u20137.","journal-title":"Indian J Nephrol"},{"issue":"4","key":"311_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5414\/CN107037","volume":"77","author":"N Jindal","year":"2012","unstructured":"Jindal N, Yadav D, Passero C, et al. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. Clin Nephrol. 2012;77(4):321\u20138.","journal-title":"Clin Nephrol"},{"issue":"10","key":"311_CR14","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheumat. 2012;64(10):3061\u20137.","journal-title":"Arthritis Rheumat"},{"key":"311_CR15","doi-asserted-by":"publisher","first-page":"357071","DOI":"10.1155\/2012\/357071","volume":"2012","author":"K Okazaki","year":"2012","unstructured":"Okazaki K, Umehara H. Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol. 2012;2012:357071.","journal-title":"Int J Rheumatol"},{"issue":"2","key":"311_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.ajkd.2011.05.006","volume":"58","author":"FC Fervenza","year":"2011","unstructured":"Fervenza FC, Downer G, Beck LH Jr, et al. IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis. 2011;58(2):320\u20134.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"311_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1523-1755.2005.00415.x","volume":"68","author":"A Kuroki","year":"2005","unstructured":"Kuroki A, Iyoda M, Shibata T, et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 2005;68(1):302\u201310.","journal-title":"Kidney Int"},{"issue":"1","key":"311_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","volume":"23","author":"A Khosroshahi","year":"2011","unstructured":"Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):67\u201371.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"311_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00535-010-0221-9","volume":"45","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45(5):471\u20137.","journal-title":"J Gastroenterol"},{"issue":"1","key":"311_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91(1):57\u201366.","journal-title":"Medicine"},{"issue":"4 Suppl 98","key":"311_CR21","first-page":"66","volume":"34","author":"JH Stone","year":"2016","unstructured":"Stone JH. IgG4-related disease: pathophysiologic insights drive emerging treatment approaches. Clin Exp Rheumatol. 2016;34(4 Suppl 98):66\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"311_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00393-016-0142-y","volume":"75","author":"CA Perugino","year":"2016","unstructured":"Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75(7):681\u20136.","journal-title":"Z Rheumatol"},{"key":"311_CR23","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, et al. Development of an IgG4-RD responder index. Int J Rheumatol. 2012;2012:259408.","journal-title":"Int J Rheumatol"},{"issue":"1","key":"311_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheumat Dis. 2015;74(1):190\u20135.","journal-title":"Ann Rheumat Dis"},{"key":"311_CR25","first-page":"85","volume":"401","author":"M Lanzillotta","year":"2017","unstructured":"Lanzillotta M, Della-Torre E, Stone JH. Roles of plasmablasts and B cells in IgG4-related disease: implications for therapy and early treatment outcomes. Curr Top Microbiol Immunol. 2017;401:85\u201392.","journal-title":"Curr Top Microbiol Immunol."}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-018-0311-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-018-0311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-018-0311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T21:04:47Z","timestamp":1548968687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-018-0311-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1007\/s13730-018-0311-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"assertion":[{"value":"28 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interests to disclose. Consent, for the publication of this case report and any additional related information, was taken from the patient involved in the study. This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}